[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857 412 7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 661153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Alves", "age": 45, "title": "Senior VP & Chief Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph P. O'Connell M.D.", "age": 70, "title": "Executive Vice President of Clinical Development and Medical Affairs", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.55, "open": 2.57, "dayLow": 2.55, "dayHigh": 2.6, "regularMarketPreviousClose": 2.55, "regularMarketOpen": 2.57, "regularMarketDayLow": 2.55, "regularMarketDayHigh": 2.6, "payoutRatio": 0.0, "beta": 1.017, "forwardPE": -0.86531985, "volume": 778668, "regularMarketVolume": 778668, "averageVolume": 835066, "averageVolume10days": 2038540, "averageDailyVolume10Day": 2038540, "bid": 1.63, "ask": 2.2, "bidSize": 2, "askSize": 7, "marketCap": 110788480, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 2.66, "allTimeHigh": 46.44, "allTimeLow": 0.89, "priceToSalesTrailing12Months": 9.333487, "fiftyDayAverage": 2.0194, "twoHundredDayAverage": 1.592605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1788609, "profitMargins": 0.0, "floatShares": 25786295, "sharesOutstanding": 43108362, "sharesShort": 352361, "sharesShortPriorMonth": 533637, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0082, "heldPercentInsiders": 0.0121, "heldPercentInstitutions": 0.57456, "shortRatio": 0.29, "shortPercentOfFloat": 0.012999999, "impliedSharesOutstanding": 43108362, "bookValue": 2.678, "priceToBook": 0.9596714, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -72200000, "trailingEps": -1.7, "forwardEps": -2.97, "enterpriseToRevenue": -0.151, "enterpriseToEbitda": 0.023, "52WeekChange": 1.056, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 2.57, "targetHighPrice": 3.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 112604000, "totalCashPerShare": 2.62, "ebitda": -76462000, "totalDebt": 342000, "quickRatio": 10.404, "currentRatio": 10.708, "totalRevenue": 11870000, "debtToEquity": 0.297, "revenuePerShare": 0.278, "returnOnAssets": -0.29721, "returnOnEquity": -0.49778, "grossProfits": 47883000, "freeCashflow": -42824248, "operatingCashflow": -70148000, "grossMargins": 4.03395, "ebitdaMargins": 0.0, "operatingMargins": -0.03701, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Repare Therapeutics Inc.", "longName": "Repare Therapeutics Inc.", "fiftyTwoWeekLowChange": 1.68, "fiftyTwoWeekLowChangePercent": 1.8876405, "fiftyTwoWeekRange": "0.89 - 2.66", "fiftyTwoWeekHighChange": -0.09000015, "fiftyTwoWeekHighChangePercent": -0.033834644, "fiftyTwoWeekChangePercent": 105.6, "earningsTimestampStart": 1763154000, "earningsTimestampEnd": 1763154000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.7, "epsForward": -2.97, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "postMarketChangePercent": -0.36575451, "postMarketPrice": 2.5606, "postMarketChange": -0.009399891, "regularMarketChange": 0.02, "regularMarketDayRange": "2.55 - 2.6", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 835066, "fiftyDayAverageChange": 0.55060005, "fiftyDayAverageChangePercent": 0.27265528, "twoHundredDayAverageChange": 0.97739494, "twoHundredDayAverageChangePercent": 0.6137083, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "cryptoTradeable": false, "regularMarketChangePercent": 0.784313, "regularMarketPrice": 2.57, "corporateActions": [], "postMarketTime": 1766796796, "regularMarketTime": 1766782800, "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]